down arrow

Xenetic Biosciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US9840156023
  • NASDAQ: XBIO
USD
2.57
-0.42 (-14.05%)

Sep 22

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sunshine Biopharma, Inc.
Xenetic Biosciences, Inc.
Tenax Therapeutics, Inc.
Inhibikase Therapeutics, Inc.
Galera Therapeutics, Inc.
Lexaria Bioscience Corp.
Titan Pharmaceuticals, Inc.
Pulmatrix, Inc.
Oragenics, Inc.
Protagenic Therapeutics, Inc.
Comera Life Sciences Holdings, Inc.

Why is Xenetic Biosciences, Inc. ?

1
Flat results in Jun 26
  • OPERATING PROFIT(Q) Lowest at USD -0.97 MM
  • PRE-TAX PROFIT(Q) Lowest at USD -0.93 MM
  • NET PROFIT(Q) Lowest at USD -0.93 MM
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -17.63%, its profits have risen by 17.8%
3
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -1.63% over the previous quarter and collectively hold 11.03% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -17.63% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Xenetic Biosciences, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Xenetic Biosciences, Inc.
-17.63%
-0.19
177.19%
S&P 500
15.76%
1.22
13.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
28.77%
EBIT Growth (5y)
6.91%
EBIT to Interest (avg)
-4.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.40
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.66%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.85
EV to EBIT
0.56
EV to EBITDA
0.56
EV to Capital Employed
1.58
EV to Sales
-0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
283.46%
ROE (Latest)
-36.25%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -2.32 MM

NET PROFIT(HY)

Higher at USD -1.39 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-9What is not working for the Company
OPERATING PROFIT(Q)

Lowest at USD -0.97 MM

PRE-TAX PROFIT(Q)

Lowest at USD -0.93 MM

NET PROFIT(Q)

Lowest at USD -0.93 MM

Here's what is working for Xenetic Biosciences, Inc.

Operating Cash Flow
Highest at USD -2.32 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Xenetic Biosciences, Inc.

Pre-Tax Profit
At USD -0.93 MM has Fallen at -66.46%
over average net sales of the previous four periods of USD -0.56 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -0.93 MM has Fallen at -66.46%
over average net sales of the previous four periods of USD -0.56 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit
Lowest at USD -0.97 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -0.93 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -0.93 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Footer loading